Filing Details

Accession Number:
0001689938-17-000007
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-12-19 18:54:57
Reporting Period:
2017-12-14
Accepted Time:
2017-12-19 18:54:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1585364 Perrigo Co Plc PRGO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1689938 John Wesolowski C/O Perrigo Company Plc
515 Eastern Avenue
Allegan MI 49010
Evp, President Rx No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2017-12-14 700 $85.80 709 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 200 Indirect 401(k)
Footnotes
  1. The reporting person's common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 700 shares, with the reporting person's sales of: (i) 220 shares of Perrigo common stock at $86.86 per share on November 28, 2017, (ii) 68 shares of Perrigo common stock at $87.64 per share on November 29, 2017, (iii) 100 shares of Perrigo common stock at $87.66 per share on November 29, 2017, and (iv) 312 of 450 shares of Perrigo common stock at $83.09 per share on December 7, 2017. The reporting person has paid Perrigo $544.02, representing the full amount of the profit realized in connection with the short-swing transaction.